NASDAQ : PBYI
Puma Biotechnology, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 10.54 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 544.08M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Puma Biotechnology, Inc. (PBYI) reported revenue of 231.24M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 231.24M | 228.37M | 230.47M | 235.64M | 228.03M | 253.16M |
| Cost of Revenue | 58.20M | 58.16M | 64.40M | 62.68M | 55.09M | 63.70M |
| Gross Profit | 173.04M | 170.21M | 166.06M | 172.96M | 172.94M | 189.45M |
| Selling, General & Admin | 71.17M | 70.85M | 80.16M | 89.93M | 89.98M | 116.29M |
| Research & Development | 71.44M | 62.07M | 54.94M | 50.38M | 52.24M | 71.87M |
| Operating Expenses | 142.61M | 132.91M | 135.10M | 140.31M | 142.22M | 188.16M |
| Operating Income | 30.44M | 37.30M | 30.97M | 32.64M | 30.72M | 1.29M |
| Interest Expense | -3.52M | -6.62M | -12.45M | -13.33M | -11.59M | -12.81M |
| Interest & Investment Income | 3.85M | 4.08M | 4.72M | 2.60M | 813.00K | 160.00K |
| Other Non Operating Income (Expenses) | 397.00K | 1.03M | 862.00K | 759.00K | -28.00K | 292.00K |
| EBT Excluding Unusual Items | 31.17M | 35.78M | 24.10M | 22.67M | 19.91M | -11.06M |
| Legal Settlements | -12.46M | -9.59M | ||||
| Other Unusual Items | -8.15M | |||||
| Pretax Income | 31.17M | 35.78M | 24.10M | 22.67M | 457.00K | -28.80M |
| Income Tax Expense | 4.45M | 4.67M | -6.18M | 1.08M | 455.00K | 324.00K |
| Net Income | 26.72M | 31.11M | 30.28M | 21.59M | 2.00K | -29.13M |
| Net Income to Common | 26.72M | 31.11M | 30.28M | 21.59M | 2.00K | -29.13M |
| Shares Outstanding (Basic) | 50.63M | 50.01M | 48.65M | 47.13M | 44.67M | 40.64M |
| Shares Outstanding (Diluted) | 51.79M | 50.65M | 49.10M | 47.55M | 44.93M | 40.64M |
| EPS (Basic) | 0.53 | 0.62 | 0.62 | 0.46 | 0.00 | -0.72 |
| EPS (Diluted) | 0.50 | 0.61 | 0.62 | 0.45 | 0.00 | -0.72 |
| Free Cash Flow | 41.16M | 41.73M | 38.86M | 26.87M | -15.83M | 20.65M |
| Free Cash Flow Per Share | 0.80 | 0.82 | 0.79 | 0.56 | -0.35 | 0.51 |
| Gross Margin | 74.83% | 74.53% | 72.06% | 73.40% | 75.84% | 74.84% |
| Operating Margin | 13.16% | 16.33% | 13.44% | 13.85% | 13.47% | 0.51% |
| Profit Margin | 11.55% | 13.62% | 13.14% | 9.16% | 0.00% | -11.51% |
| Free Cash Flow Margin | 17.80% | 18.27% | 16.86% | 11.40% | -6.94% | 8.16% |
| EBITDA | 40.12M | 47.44M | 41.09M | 42.86M | 40.56M | 12.60M |
| EBITDA Margin | 17.35% | 20.77% | 17.83% | 18.19% | 17.79% | 4.98% |
| D&A For EBITDA | 9.68M | 10.14M | 10.12M | 10.22M | 9.84M | 11.30M |
| EBIT | 30.44M | 37.30M | 30.97M | 32.64M | 30.72M | 1.29M |
| EBIT Margin | 13.16% | 16.33% | 13.44% | 13.85% | 13.47% | 0.51% |
| Effective Tax Rate | 14.28% | 13.05% | 4.78% | 99.56% | ||
| Revenue as Reported | 231.24M | 228.37M | 230.47M | 235.64M | 228.03M | 253.16M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 36.54M | 29.64M | 69.22M | 84.58M | 76.20M | 63.13M |
| Short-Term Investments | 57.37M | 67.89M | 31.75M | 11.35M | 4.87M | 18.98M |
| Cash & Short-Term Investments | 93.90M | 97.53M | 100.97M | 95.94M | 81.07M | 82.11M |
| Accounts Receivable | 34.06M | 53.65M | 32.01M | 47.84M | 40.35M | 32.53M |
| Other Receivables | 1.92M | |||||
| Receivables | 34.06M | 53.65M | 32.01M | 47.84M | 42.27M | 32.53M |
| Inventory | 13.32M | 5.51M | 8.72M | 7.08M | 4.53M | 7.11M |
| Prepaid Expenses | 1.60M | 1.63M | 1.83M | 2.48M | 2.62M | 8.98M |
| Restricted Cash | 2.09M | 8.85M | ||||
| Other Current Assets | 2.18M | 2.27M | 4.13M | 2.85M | 3.79M | 447.00K |
| Total Current Assets | 145.07M | 162.69M | 147.66M | 156.19M | 134.28M | 140.02M |
| Property, Plant & Equipment | 4.52M | 5.56M | 5.09M | 8.65M | 12.51M | 15.77M |
| Other Intangible Assets | 36.52M | 41.39M | 51.13M | 60.87M | 70.61M | 66.12M |
| Long-Term Deferred Tax Assets | 3.83M | 3.83M | 7.08M | |||
| Long-Term Deferred Charges | 97.00K | 101.00K | 102.00K | 210.00K | 577.00K | |
| Other Long-Term Assets | 2.69M | 2.73M | 2.27M | 4.62M | 4.66M | 4.09M |
| Total Assets | 192.74M | 216.30M | 213.33M | 230.53M | 222.06M | 226.59M |
| Accounts Payable | 3.10M | 5.06M | 5.51M | 6.89M | 6.44M | 11.17M |
| Accrued Expenses | 28.16M | 35.82M | 26.07M | 35.63M | 32.73M | 24.03M |
| Current Portion of Long-Term Debt | 22.52M | 45.33M | 34.00M | |||
| Current Portion of Leases | 450.00K | 1.31M | 5.54M | 4.80M | 4.14M | 3.57M |
| Other Current Liabilities | 18.11M | 16.54M | 13.66M | 18.07M | 34.17M | 70.81M |
| Total Current Liabilities | 49.83M | 81.25M | 96.11M | 99.38M | 77.48M | 109.59M |
| Long-Term Debt | 21.72M | 65.66M | 98.31M | 97.09M | ||
| Long-Term Leases | 4.37M | 4.71M | 1.49M | 7.03M | 11.83M | 15.97M |
| Other Long-Term Liabilities | 1.88M | 5.01M | 12.83M | 6.38M | ||
| Total Liabilities | 54.19M | 85.96M | 121.21M | 177.09M | 200.45M | 229.03M |
| Common Stock | 5.00K | 5.00K | 5.00K | 5.00K | 5.00K | 4.00K |
| Additional Paid-In Capital | 1.42B | 1.41B | 1.41B | 1.40B | 1.39B | 1.36B |
| Retained Earnings | -1.28B | -1.28B | -1.31B | -1.35B | -1.37B | -1.37B |
| Comprehensive Income & Other | -45.00K | 36.00K | 6.00K | -4.00K | -2.00K | |
| Shareholders' Equity | 138.54M | 130.34M | 92.12M | 53.44M | 21.61M | -2.45M |
| Total Liabilities & Equity | 192.74M | 216.30M | 213.33M | 230.53M | 222.06M | 226.59M |
| Total Debt | 4.82M | 28.55M | 74.08M | 111.49M | 114.28M | 116.64M |
| Net Cash (Debt) | 89.09M | 68.98M | 26.88M | -15.55M | -33.21M | -34.53M |
| Net Cash Per Share | 1.72 | 1.36 | 0.55 | -0.33 | -0.74 | -0.85 |
| Filing Date Shares Outstanding | 51.62M | 50.88M | 49.61M | 48.21M | 46.64M | 41.33M |
| Total Common Shares Outstanding | 51.10M | 50.41M | 49.11M | 47.65M | 46.35M | 41.18M |
| Working Capital | 95.25M | 81.43M | 51.55M | 56.80M | 56.80M | 30.44M |
| Book Value Per Share | 2.71 | 2.59 | 1.88 | 1.12 | 0.47 | -0.06 |
| Tangible Book Value | 102.02M | 88.95M | 40.99M | -7.43M | -49.00M | -68.57M |
| Tangible Book Value Per Share | 2.00 | 1.76 | 0.83 | -0.16 | -1.06 | -1.67 |
| Machinery | 1.32M | 2.24M | 4.60M | 4.76M | 4.79M | 4.84M |
| Leasehold Improvements | 1.70M | 2.55M | 3.78M | 3.78M | 3.78M | 3.78M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 26.72M | 31.11M | 30.28M | 21.59M | 2.00K | -29.13M |
| Depreciation & Amortization | 9.68M | 10.14M | 10.12M | 10.22M | 9.84M | 11.30M |
| Other Amortization | 800.00K | 800.00K | 1.40M | 1.30M | ||
| Loss (Gain) From Sale of Assets | 10.00K | 4.00K | ||||
| Asset Writedown & Restructuring Costs | 625.00K | 7.00M | ||||
| Stock-Based Compensation | 7.14M | 6.94M | 8.24M | 10.25M | 11.83M | 32.63M |
| Provision & Write-off of Bad Debts | -213.00K | -362.00K | -519.00K | 881.00K | -1.00M | |
| Other Operating Activities | 3.25M | 3.25M | -7.08M | 1.00K | 8.15M | |
| Change in Accounts Receivable | -7.94M | -21.28M | 16.34M | -8.37M | -7.82M | -5.98M |
| Change in Inventory | -4.73M | 3.21M | -1.64M | -2.55M | 2.58M | -3.65M |
| Change in Accounts Payable | -2.32M | -453.00K | -1.38M | 449.00K | -4.73M | -902.00K |
| Change in Other Net Operating Assets | 8.76M | 8.45M | -16.86M | -7.38M | -34.52M | 9.23M |
| Operating Cash Flow | 41.15M | 41.80M | 38.92M | 27.01M | -15.83M | 20.65M |
| Capital Expenditures | 10.00K | -71.00K | -56.00K | -140.00K | ||
| Sale (Purchase) of Intangibles | -12.50M | -7.00M | ||||
| Investment in Securities | -16.04M | -36.12M | -20.38M | -6.49M | 14.10M | -10.88M |
| Investing Cash Flow | -16.02M | -36.19M | -20.44M | -19.12M | 7.10M | -10.88M |
| Long-Term Debt Issued | 98.50M | |||||
| Long-Term Debt Repaid | -44.44M | -33.33M | -100.00M | |||
| Net Debt Issued (Repaid) | -44.45M | -44.44M | -33.33M | -1.50M | ||
| Issuance of Common Stock | 130.00K | 150.00K | 12.50M | |||
| Other Financing Activities | -889.00K | -888.00K | -666.00K | -277.00K | -30.43M | |
| Financing Cash Flow | -45.34M | -45.20M | -33.85M | 12.22M | -31.93M | |
| Net Cash Flow | -20.22M | -39.58M | -15.37M | 7.88M | 3.50M | -22.16M |
| Free Cash Flow | 41.16M | 41.73M | 38.86M | 26.87M | -15.83M | 20.65M |
| Free Cash Flow Margin | 17.80% | 18.27% | 16.86% | 11.40% | -6.94% | 8.16% |
| Free Cash Flow Per Share | 0.80 | 0.82 | 0.79 | 0.56 | -0.35 | 0.51 |
| Levered Free Cash Flow | 32.47M | 30.69M | 29.49M | 1.40M | -1.34M | 8.08M |
| Unlevered Free Cash Flow | 33.87M | 34.03M | 35.88M | 8.43M | 5.91M | 16.08M |
| Cash Interest Paid | 3.05M | 5.82M | 10.77M | 11.63M | 10.32M | 10.34M |
| Cash Income Tax Paid | 1.12M | 1.52M | 1.22M | 737.00K | 384.00K | 324.00K |
| Change in Working Capital | -6.23M | -10.08M | -3.54M | -17.85M | -44.50M | -1.31M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 538.91M | 299.83M | 149.72M | 205.98M | 196.04M | 124.29M |
| Enterprise Value | 449.83M | 246.49M | 139.36M | 233.18M | 232.99M | 153.92M |
| Last Close Price | 10.44 | 5.95 | 3.05 | 4.33 | 4.23 | 3.04 |
| PE Ratio | 20.73 | 9.64 | 4.95 | 9.54 | 98,021.07 | |
| Forward PE | 12.55 | 11.62 | 10.57 | 33.92 | 127.83 | |
| PS Ratio | 2.33 | 1.31 | 0.65 | 0.87 | 0.86 | 0.49 |
| PB Ratio | 3.85 | 2.30 | 1.62 | 3.85 | 9.07 | -50.81 |
| P/TBV Ratio | 5.28 | 3.37 | 3.65 | |||
| P/FCF Ratio | 13.09 | 7.18 | 3.85 | 7.67 | 6.02 | |
| P/OCF Ratio | 13.10 | 7.17 | 3.85 | 7.63 | 6.02 | |
| PEG Ratio | 25.68 | 25.68 | 25.68 | 25.68 | 25.68 | |
| EV/Sales Ratio | 1.95 | 1.08 | 0.60 | 0.99 | 1.02 | 0.61 |
| EV/EBITDA Ratio | 11.21 | 5.20 | 3.39 | 5.44 | 5.74 | 12.22 |
| EV/EBIT Ratio | 14.78 | 6.61 | 4.50 | 7.14 | 7.58 | 119.31 |
| EV/FCF Ratio | 10.93 | 5.91 | 3.59 | 8.68 | 7.45 | |
| Debt / Equity Ratio | 0.04 | 0.22 | 0.80 | 2.09 | 5.29 | -47.69 |
| Debt / EBITDA Ratio | 0.11 | 0.56 | 1.66 | 2.33 | 2.54 | 6.78 |
| Debt / FCF Ratio | 0.12 | 0.68 | 1.91 | 4.15 | 5.65 | |
| Net Debt / Equity Ratio | -0.64 | -0.53 | -0.29 | 0.29 | 1.54 | -14.12 |
| Net Debt / EBITDA Ratio | -2.22 | -1.45 | -0.65 | 0.36 | 0.82 | 2.74 |
| Net Debt / FCF Ratio | -2.16 | -1.65 | -0.69 | 0.58 | -2.10 | 1.67 |
| Asset Turnover | 1.19 | 1.06 | 1.04 | 1.04 | 1.02 | 1.07 |
| Inventory Turnover | 5.31 | 8.17 | 8.15 | 10.80 | 9.47 | 12.06 |
| Quick Ratio | 2.57 | 1.86 | 1.38 | 1.45 | 1.59 | 1.05 |
| Current Ratio | 2.91 | 2.00 | 1.54 | 1.57 | 1.73 | 1.28 |
| Return on Equity (ROE) | 21.97% | 27.97% | 41.60% | 57.54% | 0.02% | |
| Return on Assets (ROA) | 9.81% | 10.85% | 8.72% | 9.01% | 8.56% | 0.34% |
| Return on Invested Capital (ROIC) | 56.55% | 51.23% | 46.14% | 50.21% | 0.16% | 1.04% |
| Return on Capital Employed (ROCE) | 21.30% | 27.60% | 26.40% | 24.90% | 21.20% | 1.10% |
| Earnings Yield | 4.82% | 10.38% | 20.22% | 10.48% | 0.00% | -23.43% |
| FCF Yield | 7.64% | 13.92% | 25.96% | 13.04% | -8.07% | 16.61% |
| Buyback Yield / Dilution | -3.62% | -3.16% | -3.26% | -5.83% | -10.56% | -2.69% |